Results 151 to 160 of about 581,647 (319)
RETRACTION: Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis
World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView., 2023 Retraction: Tan, DJY, Ko, TK. Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis. World J Otorhinolaryngol Head Neck Surg. 2023; 1–8. doi:10.1002/wjo2.125. The above article, published online on 28 July 2023 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal's Editor ...
Denise Jia Yun Tan, Tsz Ki Ko
wiley +1 more source
Mental health during the coronavirus disease 2019 (Covid-19) pandemic: more is still to be done
, 2020 Francky Teddy Endomba +2 more
openalex +1 more source
Fertility and Early Embryonic Development Toxicity of hzVSF‐v13 in Sprague–Dawley Rats
Journal of Applied Toxicology, EarlyView.ABSTRACT Humanized virus suppressing factor–variant 13 (hzVSF‐v13), a monoclonal IgG4 antibody, is a potential therapeutic candidate for COVID‐19. Although fertility and embryonic developmental toxicity studies are crucial for the safety evaluation of new drugs, the toxicological profile of hzVSF‐v13 remains unexplored.
Ji‐Seong Jeong +10 more
wiley +1 more source
Psychiatric‐mental health nursing leadership during coronavirus disease 2019 (COVID‐19) [PDF]
, 2020 Brayden Kameg
openalex +1 more source
The Role of Viral and Bacterial Infections in the Etiology of Behçet's Disease
Journal of Clinical Laboratory Analysis, EarlyView.Bacterial and viral pathogens may play a key role in Behçet's disease (BD) pathogenesis by triggering autoimmunity, molecular mimicry, or microbiome disruption. These infectious agents could initiate inflammatory pathways, contributing to BD's diverse clinical manifestations.
Mohsen Moghoofei +4 more
wiley +1 more source
An Update of Coronavirus Disease 2019 (COVID-19): An Essential Brief for Clinicians
, 2021 Afshin Zare +10 more
openalex +1 more source
The Journal of Clinical Pharmacology, EarlyView.Abstract Posdinemab, a humanized immunoglobulin G1/κ monoclonal antibody, binds with high affinity to phosphorylated tau protein which is associated with Alzheimer's disease (AD) pathophysiology. Posdinemab reduced tau seeding in murine models and was well tolerated in Phase‐1 clinical studies.
Fangfang Wang +7 more
wiley +1 more source